Dr. P K Das
Sr. Consultant - Medical Oncologist - Indraprastha Apollo Hospitals, New Delhi
Consults at:
About
Currently employed at Apollo Cancer Institute in New Delhi as a senior consultant medical oncologist, haemato-oncologist, and academic coordinator.
Dr. P.K. Das has worked at Apollo Hospital in Delhi for the past 15 years and is in head of Medical Oncology Unit I. He received his training at AIIMS, New Delhi.
For the previous nine years, he had the pleasure of working alongside Professor Suresh H. Advani, who was in charge of his unit at the Apollo Cancer Institute in New Delhi.
Specialty: Oncology
Education
- MBBS
- MD - General Medicine
- DM - Medical Oncology
Hospitals
Awards
Memberships
Indian Society of Medical & Pediatric Oncology member (ISMPO)
European Society of Medical Oncology (ESMO) life member, membership number 258234
American Society of Clinical Oncology member (ASCO)
Drug Controller General of India Member Expert Committee
Member of the expert advisory committee on oncology for six planned AIIMS Centers, which is part of the Indian government's ministry of health and family welfare.
Awards and Achievements
The Association of Physicians of India Conference in Berhampur featured a presentation on the use of recombinant erythropoietin in the treatment of anaemia in chronic renal failure (ORISSA)
The poster, "Role of Circulating Megakaryocytes in CML," which was presented at the 11th International Congress on Anti-Cancer Treatment in Paris, France, in February 2001, won first place. This task has only recently been completed in India.
A case report from the postgraduate medical journal from 2000, Vol. 76, Pg. 704–709, describes a patient with acute myeloid leukaemia who also had "disseminated fungal infection associated with pulmonary haemorrhage."
Kidney extraosseous Ewing's sarcoma: A case report from Urologic Internationals, June 2001
An analysis of the significance of the oncoprotein C-erbB-2 in uterine cervix squamous cell carcinoma and its response to therapy was given as a poster at the ASCO PAN ASIA Cancer Conference in New Delhi in February 20025.
The Indian Journal of Medical Research accepted the study's analysis of risk variables and chromosomal abnormalities in North Indian leukaemia patients for publication in October 2005.
Published in the Indian Journal of Cancer, Panigrahi M, DAS P.K. et al. Jan-March 2011, volume 48, issue 1, pages 11-17, "Brain Tumor with Gliadel Wafer Treatment."